BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35090172)

  • 21. Multiplex ligation-dependent probe amplification screening of isolated increased HbF levels revealed three cases of novel rearrangements/deletions in the beta-globin gene cluster.
    Lee ST; Yoo EH; Kim JY; Kim JW; Ki CS
    Br J Haematol; 2010 Jan; 148(1):154-60. PubMed ID: 19807730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression.
    Calzolari R; McMorrow T; Yannoutsos N; Langeveld A; Grosveld F
    EMBO J; 1999 Feb; 18(4):949-58. PubMed ID: 10022837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
    Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
    J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of γ-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin.
    Doerfler PA; Feng R; Li Y; Palmer LE; Porter SN; Bell HW; Crossley M; Pruett-Miller SM; Cheng Y; Weiss MJ
    Nat Genet; 2021 Aug; 53(8):1177-1186. PubMed ID: 34341563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA sequences regulating human globin gene transcription in nondeletional hereditary persistence of fetal hemoglobin.
    Ottolenghi S; Mantovani R; Nicolis S; Ronchi A; Giglioni B
    Hemoglobin; 1989; 13(6):523-41. PubMed ID: 2481658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Analysis of an (A)γ-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress.
    Ugrin M; Stojiljkovic M; Zukic B; Klaassen K; Katsila T; Vasiljevic J; Dokmanovic L; Janic D; Patrinos GP; Pavlovic S
    Hemoglobin; 2016; 40(1):48-52. PubMed ID: 26575252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
    Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
    Bauer DE; Orkin SH
    Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India.
    Hariharan P; Kishnani P; Sawant P; Gorivale M; Mehta P; Kargutkar N; Colah R; Nadkarni A
    Ann Hematol; 2020 Jul; 99(7):1475-1483. PubMed ID: 32524201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of hereditary persistence of fetal hemoglobin.
    Forget BG
    Ann N Y Acad Sci; 1998 Jun; 850():38-44. PubMed ID: 9668525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and characterisation of beta-globin gene cluster deletions in Chinese using multiplex ligation-dependent probe amplification.
    So CC; So AC; Chan AY; Tsang ST; Ma ES; Chan LC
    J Clin Pathol; 2009 Dec; 62(12):1107-11. PubMed ID: 19946097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin.
    Masuda T; Wang X; Maeda M; Canver MC; Sher F; Funnell AP; Fisher C; Suciu M; Martyn GE; Norton LJ; Zhu C; Kurita R; Nakamura Y; Xu J; Higgs DR; Crossley M; Bauer DE; Orkin SH; Kharchenko PV; Maeda T
    Science; 2016 Jan; 351(6270):285-9. PubMed ID: 26816381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation patterns of β-globin cluster in β-thalassemia patients.
    Bao X; Zuo Y; Chen D; Zhao C
    Clin Epigenetics; 2020 Dec; 12(1):187. PubMed ID: 33272312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
    Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A
    Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies.
    Li C; Georgakopoulou A; Newby GA; Everette KA; Nizamis E; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36006707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.
    Gudmundsdottir B; Gudmundsson KO; Klarmann KD; Singh SK; Sun L; Singh S; Du Y; Coppola V; Stockwin L; Nguyen N; Tessarollo L; Thorsteinsson L; Sigurjonsson OE; Gudmundsson S; Rafnar T; Tisdale JF; Keller JR
    Cell Rep; 2018 Jun; 23(11):3236-3248. PubMed ID: 29898395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KLF1 drives the expression of fetal hemoglobin in British HPFH.
    Wienert B; Martyn GE; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
    Blood; 2017 Aug; 130(6):803-807. PubMed ID: 28659276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
    Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
    FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor.
    Martin DI; Tsai SF; Orkin SH
    Nature; 1989 Mar; 338(6214):435-8. PubMed ID: 2467208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.
    Rixon MW; Gelinas RE
    Mol Cell Biol; 1988 Feb; 8(2):713-21. PubMed ID: 2451123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.